S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
NASDAQ:AGIO

Agios Pharmaceuticals News Headlines

$46.28
-0.45 (-0.96 %)
(As of 10/15/2021 04:00 PM ET)
Add
Compare
Today's Range
$46.06
$47.40
50-Day Range
$41.92
$48.24
52-Week Range
$32.47
$62.15
Volume817,943 shs
Average Volume683,394 shs
Market Capitalization$2.73 billion
P/E Ratio2.04
Dividend YieldN/A
Beta1.57

Media Mentions By Week

Agios Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

AGIO
News Sentiment

0.36

0.32

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

AGIO Articles
This Week

3

2

AGIO Articles
Average Week

Get Agios Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter.

Agios Pharmaceuticals (NASDAQ AGIO) News Headlines Today

SourceHeadline
finance.yahoo.com logoAgios Pharmaceuticals, Inc. (AGIO)
finance.yahoo.com - October 15 at 12:52 AM
nz.finance.yahoo.com logoDelveInsight Evaluates a Robust Pipeline for Myelodysplastic Syndromes as Influential Pharma Players Set Foot in the MDS Landscape
nz.finance.yahoo.com - October 14 at 1:03 AM
ca.finance.yahoo.com logoVividion Therapeutics Announces Formation of Scientific Advisory Board
ca.finance.yahoo.com - September 22 at 8:20 AM
nasdaq.com logoShareholders in Agios Pharmaceuticals (NASDAQ:AGIO) are in the red if they invested three years ago
nasdaq.com - September 17 at 12:54 PM
finance.yahoo.com logoKyverna Therapeutics Appoints Ian Clark as Chairman of the Board and Karen Walker as Chief Technology Officer
finance.yahoo.com - September 15 at 12:58 PM
finance.yahoo.com logoAgios To Present at September Investor Conferences
finance.yahoo.com - August 30 at 8:28 AM
finance.yahoo.com logoAgios Announces FDA Acceptance and Priority Review of New Drug Application for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency
finance.yahoo.com - August 17 at 5:40 PM
finance.yahoo.com logoRheos Medicines Appoints Nirupama Subramanian as Chief Operating Officer
finance.yahoo.com - August 10 at 1:42 PM
finance.yahoo.com logoWould Shareholders Who Purchased Agios Pharmaceuticals' (NASDAQ:AGIO) Stock Three Years Be Happy With The Share price Today?
finance.yahoo.com - July 31 at 8:46 AM
seekingalpha.com logoAgios Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call Presentation
seekingalpha.com - July 30 at 11:45 AM
finance.yahoo.com logoAgios Pharmaceuticals, inc (AGIO) Q2 2021 Earnings Call Transcript
finance.yahoo.com - July 29 at 9:50 PM
finance.yahoo.com logoAgios Reports Business Highlights and Second Quarter 2021 Financial Results
finance.yahoo.com - July 29 at 11:48 AM
finance.yahoo.com logoAgios Pharmaceuticals (AGIO) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - July 29 at 11:48 AM
markets.businessinsider.com logoAgios Pharmaceuticals is about to announce its earnings — here's what Wall Street expects
markets.businessinsider.com - July 27 at 2:56 PM
finance.yahoo.com logoHere is What Hedge Funds Think About Agios Pharmaceuticals Inc (AGIO)
finance.yahoo.com - July 19 at 2:19 PM
nasdaq.com logoAnalysts Expect Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) To Breakeven Soon
nasdaq.com - July 19 at 9:19 AM
nasdaq.com logoAgios Pharmaceuticals, Inc. Common Stock (AGIO)
nasdaq.com - July 16 at 7:08 PM
benzinga.com logoSickle Cell Disease Market in North America to Surpass US$ 2,200.5 Million by 2028, Says Coherent Market Insights (CMI)
benzinga.com - July 16 at 9:07 AM
finance.yahoo.com logoAgios to Webcast Conference Call of Second Quarter 2021 Financial Results on July 29, 2021
finance.yahoo.com - July 15 at 8:54 AM
bizjournals.com logoBroad Institute spinout launches with $315M for new gene-editing tech
bizjournals.com - July 14 at 8:21 AM
finance.yahoo.com logoAgios Submits Marketing Authorisation Application to European Medicines Agency for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency
finance.yahoo.com - June 28 at 9:35 AM
finance.yahoo.com logoAgios (AGIO) Files NDA to FDA for Rare Disease Drug Mitapivat
finance.yahoo.com - June 22 at 12:47 PM
finance.yahoo.com logoAgios Launches myAgios® Patient Support Services for Pyruvate Kinase Deficiency
finance.yahoo.com - June 22 at 7:37 AM
finance.yahoo.com logoAgios Pharma Files US Application For Mitapivat In PK Deficiency
finance.yahoo.com - June 21 at 2:59 PM
marketwatch.com logoAgios Files for FDA OK of Mitapivat in PK Deficiency >AGIO
marketwatch.com - June 21 at 9:59 AM
finance.yahoo.com logoAgios Submits New Drug Application to FDA for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency
finance.yahoo.com - June 21 at 9:59 AM
nasdaq.com logoFirst Week of July 16th Options Trading For Agios Pharmaceuticals
nasdaq.com - June 11 at 2:20 PM
finance.yahoo.com logoAgios Pharmaceuticals, Inc. (AGIO.MX)
finance.yahoo.com - June 6 at 12:33 AM
finance.yahoo.com logoAgios to Present Updated Data from Clinical Trials of Mitapivat in Pyruvate Kinase Deficiency and Thalassemia in Oral Presentations at the European Hematology Association Annual Congress
finance.yahoo.com - May 12 at 12:56 PM
MarketBeat logoAgios Pharmaceuticals (NASDAQ:AGIO) Price Target Raised to $65.00
americanbankingnews.com - May 6 at 8:58 AM
ca.finance.yahoo.com logoAffinivax Appoints Elizabeth Radcliffe as Chief Financial Officer
ca.finance.yahoo.com - May 5 at 12:58 PM
finance.yahoo.com logoAgios Pharmaceuticals, Inc. (NASDAQ:AGIO) Is About To Turn The Corner
finance.yahoo.com - May 2 at 10:41 AM
finance.yahoo.com logoAgios' (AGIO) Q1 Earnings Miss, Pipeline Makes Progress
finance.yahoo.com - April 30 at 10:40 AM
finance.yahoo.com logoAgios Pharmaceuticals Inc (AGIO) Q1 2021 Earnings Call Transcript
finance.yahoo.com - April 29 at 6:45 PM
nasdaq.com logoDoes Agios Pharmaceuticals (NASDAQ:AGIO) Have A Healthy Balance Sheet?
nasdaq.com - April 29 at 1:44 PM
finance.yahoo.com logoAgios Pharmaceuticals (AGIO) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - April 29 at 1:44 PM
finance.yahoo.com logoAgios Reports Business Highlights and First Quarter 2021 Financial Results
finance.yahoo.com - April 29 at 8:44 AM
finance.yahoo.com logoIs AGIO Stock A Buy or Sell?
finance.yahoo.com - April 20 at 3:19 PM
uk.finance.yahoo.com logoAGIO May 2021 70.000 call
uk.finance.yahoo.com - April 18 at 10:01 PM
nasdaq.com logoInteresting AGIO Put And Call Options For June 18th
nasdaq.com - April 16 at 5:37 PM
finance.yahoo.com logoAgios to Webcast Conference Call of First Quarter 2021 Financial Results on April 29, 2021
finance.yahoo.com - April 15 at 10:08 AM
marketwatch.com logoTibsovo Market 2021 Top manufacturers Records are Agios Pharmaceuticals, Share & Trends Analysis 2025
marketwatch.com - April 8 at 8:12 AM
finance.yahoo.com logoServier Completes Acquisition of Agios Pharmaceuticals' Oncology Business
finance.yahoo.com - April 1 at 9:26 AM
finance.yahoo.com logoAgios Announces Closing of Oncology Business Sale to Servier
finance.yahoo.com - April 1 at 9:26 AM
marketwatch.com logoLymphoma Treatment Market to be Led by Bayer AG and Novartis AG, sates Fortune Business Insights™
marketwatch.com - March 30 at 2:34 PM
finance.yahoo.com logoWhy Is Agios Pharmaceuticals (AGIO) Down 1.3% Since Last Earnings Report?
finance.yahoo.com - March 27 at 3:23 PM
finance.yahoo.com logoAgios Shareholders Approve Sale of Oncology Business to Servier
finance.yahoo.com - March 25 at 6:13 PM
markets.businessinsider.com logoIonis Pharmaceuticals Helps Lead The Biotechnology Sector Lower
markets.businessinsider.com - March 23 at 2:20 PM
finance.yahoo.com logoAgios Sponsors Program Promoting Health Literacy for Patients with Sickle Cell Disease
finance.yahoo.com - March 18 at 8:37 AM
finance.yahoo.com logoCholangiocarcinoma Pipeline Insight: Therapeutic analysis of 70+ pipeline therapies and 70+ pharmaceutical companies
finance.yahoo.com - March 16 at 11:54 PM
Get Agios Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/16/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.